Literature DB >> 6432408

Worldwide clinical experience with auranofin.

R W Morris, D S Cole, J Horton, M A Heuer, R G Pietrusko.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432408     DOI: 10.1007/bf03342628

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.

Authors:  A Larsen; J Horton; C Howland
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

2.  A single-blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis.

Authors:  H A Bird; P Le Gallez; J S Dixon; K E Surrall; D S Cole; M H Goldman; V Wright
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

3.  Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalate.

Authors:  D Lewis; H A Capell
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

4.  Auranofin. New oral gold compound for treatment of rheumatoid arthritis.

Authors:  A E Finkelstein; D T Walz; V Batista; M Mizraji; F Roisman; A Misher
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

5.  Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.

Authors:  H A Menard; F Beaudet; P Davis; M Harth; J S Percy; A S Russell; J M Thompson
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug

6.  Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.

Authors:  P L van Riel; F W Gribnau; L B van de Putte; S H Yap
Journal:  J Rheumatol       Date:  1983-04       Impact factor: 4.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.